More UK research debunks FDA’s claim that e-cigarettes are ‘gateway’ to smoking
A new study from the UK Centre for Substance Use Research (CSUR) published last week shows e-cigarettes and vaping devices are acting as a deterrent or “roadblock” to teen smoking. This new data is in direct opposition to the many claims made by the U.S. Food and Drug Administration (FDA) that e-cigs are a gateway to combustible tobacco products.
A single medical study would not normally be considered enormously relevant here in the United States. However, the UK’s CSUR is very highly regarded around the world as a non-biased and reliable authority on substance abuse. When the latest CSUR study is combined with similar research conducted by Great Britain’s Royal College of Physicians just a few days before the announcement of the new FDA e-cig regulations, many American journalists are further questioning the FDA’s true motives.
The CSUR study was conducted by Dr. Neil McKeganey from Glasgow, and for the purposes of full disclosure, the study was funded by a company named Fontem Ventures, a developer of non-tobacco products and a subsidiary of Imperial Tobacco. This is important because so much of the anti-vaping “research” currently being released in the United States is eventually discovered to be bogus online propaganda that is merely masquerading as scientific research. These reports are also frequently discovered to be secretly funded by the FDA, the Center for Disease Control (CDC), or the American Cancer Society – all agencies that would financially benefit from the new FDA e-cig regulations.
(Related Article: BREAKING NEWS: BOGUS USC ‘STUDY’ ON TEEN SMOKING RATES FUNDED BY THE FDA)
But Imperial Tobacco is slightly different. This company develops and markets both combustible tobacco and electronic cigarette products. Why would such an organization fund medical research by the CSUR on e-cigs vs. tobacco? Perhaps Imperial is attempting to determine which industry will be the most profitable in the coming decades.
Or maybe the company is simply trying to decide which product is more addictive than the other? Whatever the reason, the Imperial Tobacco is essentially a member of Big Tobacco, and its funding of the research needs to be taken into account when reviewing the results of the CSUR study.
Furthermore, the CSUR study reportedly only involved the interviewing of several young people from the ages of 16 to 25 in both England and Scotland. To put this another way, the “study” was essentially nothing more than a marketing research survey. But some of the participants’ comments on e-cigs and tobacco are rather interesting.
“It’s more concerning, particularly for the young people who currently smoke, that inaccurate perceptions of e-cigarettes could result in the persistent use of combustible tobacco irrespective of the fact that Public Health England has concluded vaping is 95 percent less harmful than conventional cigarettes.”
-Dr. Neil McKeganey
Since the May 5, 2016 announcement of the FDA e-cig regulations, the FDA has been under attack for a perceived conflict of interest where many of the agency’s key decision makers are suspected of being “in the pocket” of Big Pharma companies like GlaxoSmithKline, manufacturer of “The Patch,” and Johnson & Johnson, the company behind Nicorette Gum. When new research statistics come from outside of the United States that debunk current FDA-funded data, like those from the CSUR and the Royal College of Physicians, this only adds more fuel to the fires of controversy over the FDA e-cig regulations here in the United States.
The opinions expressed in this article are those of the author's and do not necessarily represent the viewpoints, policy or company position of Vapes.com, the rest of our staff, and/or any/all contributors to this site.